Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
BioRestorative Therapies, Inc.
| Metric | BioRestorative Therapies, Inc. BRTXHealthcare |
|---|---|
| Quality Score | 43 / 100 |
| Revenue (latest) | $359,700 |
| Net income (latest) | −$14M |
| Operating margin | −4350.1% |
| Net margin | −3959.4% |
| Return on equity | −3992.2% |
| Return on assets | −349.1% |
| Return on capital (ROCE) | −4386.1% |
| Debt / equity | — |
| Revenue growth (YoY) | −10.3% |
| Altman Z″ (distress) | — |
| Accruals / assets | −84.6% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.